Clinical trials
2 active trials in Hong Kong
Recruiting, about to start, or running now.
- Mindful Eating Study for Adults With Diabetes and Weight Concerns in Hong Kong NCT07692386
- Combating Physical Inactivity Pandemic in Kindergartens NCT05521490
Updated
Reviewed by Vidhi Upadhyay
Hong Kong Body Composition Analyzers Market Industry Trends and Forecast to 2034: Segmented by (Technology, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.4 Mn | — | — |
| 2025 (base) | $1.6 Mn | +$0.1 Mn | — |
| 2026 (forecast) | $1.7 Mn | +$0.1 Mn | +9.3% |
| 2027 (forecast) | $1.9 Mn | +$0.2 Mn | +19.5% |
| 2028 (forecast) | $2.0 Mn | +$0.2 Mn | +30.6% |
| 2029 (forecast) | $2.2 Mn | +$0.2 Mn | +42.7% |
| 2030 (forecast) | $2.4 Mn | +$0.2 Mn | +56% |
| 2031 (forecast) | $2.6 Mn | +$0.2 Mn | +70.5% |
| 2032 (forecast) | $2.9 Mn | +$0.2 Mn | +86.4% |
| 2033 (forecast) | $3.2 Mn | +$0.3 Mn | +103.7% |
| 2034 (forecast) | $3.5 Mn | +$0.3 Mn | +122.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $3.5 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 9.3% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Technology, product and end user (see all) |
| Key players | InBody, Tanita, Omron Healthcare, Withings, Seca and 1 more (see all) |
| Regulator in Hong Kong | MDACSSource: Medical Device Division, Department of Health. Checked 14 Nov 2026. |
| Active clinical trials | 2 in Hong KongSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 12 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Body composition analyzers measure fat, muscle and water in the body, used in clinics, gyms and homes to track health and weight-loss progress.
Key segments of the body Composition Analyzers market include technology (Bioelectrical Impedance, DEXA and Air Displacement) and product (Professional Analyzers and Smart Scales).
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the body Composition Analyzers market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.
Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the body Composition Analyzers market, especially in fast-growing emerging economies.
High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the body Composition Analyzers market. Long-term safety data and lifestyle support are still needed for many patients.
The body Composition Analyzers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Hong Kong has a voluntary listing system for medical devices (MDACS), run by the Medical Device Division of the Department of Health.[1] Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government.[2] ClinicalTrials.gov lists 2 studies on Body Composition Analyzers that are recruiting, active or about to start in Hong Kong.[3]
[1] Medical Device Division, Department of Health. Checked 14 Nov 2026.
[2] Hospital Authority. Checked 14 Nov 2026.
[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 12 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how body Composition Analyzers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Hong Kong.
What doctors and scientists are doing in Body Composition Analyzers right now, from free public sources.
2 active trials in Hong Kong
Recruiting, about to start, or running now.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Hong Kong
OTC & Nutraceuticals · Hong Kong
Pharmaceuticals · Hong Kong
OTC & Nutraceuticals · Hong Kong
Pharmaceuticals · Hong Kong
Pharmaceuticals · Hong Kong
OTC & Nutraceuticals · Hong Kong